Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
31%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
FTXH
50
HOLDINGS
33%
ALSO IN PBE
PBE
33
HOLDINGS
55%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
BIOGEN IDEC INC | 3.5% | 4.9% | 3.5% |
|
AMGEN INC | 3.3% | 4.9% | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 3.2% | 5.0% | 3.2% |
|
GILEAD SCIENCES INC | 2.9% | 4.5% | 2.9% |
|
REGENERON PHARMACEUTICALS | 2.8% | 4.7% | 2.8% |
FTXH Overweight Relative to PBE
|
ELI LILLY & CO | 7.6% |
|
ABBVIE INC | 7.5% |
|
JOHNSON & JOHNSON | 7.1% |
|
MERCK & CO. INC. | 7.1% |
|
BRISTOL-MYERS SQUIBB CO | 6.7% |
|
VIATRIS, INC. | 3.9% |
|
CARDINAL HEALTH INC | 3.4% |
|
PFIZER INC | 3.0% |
 |
JAZZ PHARMACEUTICALS PLC | 2.6% |
|
ZOETIS INC | 1.9% |
FTXH Underweight Relative to PBE
|
ROYALTY PHARMA PLC CLASS A | -4.8% |
|
ALNYLAM PHARMACEUTICALS INC | -4.2% |
|
CAREDX, INC. | -3.2% |
|
VERACYTE INC | -3.2% |
|
BIO-TECHNE CORPORATION | -3.2% |
|
REPLIGEN CORP | -3.0% |
|
VERICEL CORPORATION | -3.0% |
|
BIOCRYST PHARMACEUTICALS INC | -2.8% |
|
SAREPTA THERAPEUTICS INC | -2.8% |
|
ANAPTYSBIO, INC. | -2.6% |